MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0015958
Rini Life Science Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹57.3 Cr
▲ 8% YoY
Net profit · FY 2025
₹1.52 Cr
Net margin 2.6%
EBITDA · FY 2025
₹3.67 Cr
EBITDA margin 6.4%
Authorised capital
₹1.66 Cr
Registered with MCA
Paid-up capital
₹11.41 Lakh
Issued & subscribed
Open charges
₹2.5 Cr
Satisfied ₹86.76 Lakh
Company age
22 yrs
Est. 2004
Employees · EPFO
59
Provident fund records
About Rini Life Science Private Limited
Data last updated:
Rini Life Science Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 03 February 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51101MP2004PTC016376. Its GSTIN is 23AACCR6758H1Z8 (Madhya Pradesh).
The company has an authorised share capital of ₹1.66 Cr and a paid-up capital of ₹11.41 Lakh. It is led by directors including Rajnish Chordia (Whole-Time Director) and Rakesh Kumar Chordia (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 120 M.T. Cloth Market, Indore, Madhya Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.3 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.52 Cr (net margin 2.6%) and EBITDA of ₹3.67 Cr (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 8% over five years.
The company has about 59 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Rini Life Science. As per MCA filings, the company has open charges of ₹2.5 Cr and satisfied charges of ₹86.76 Lakh on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it; 4 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in March 2023. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Keshava Organics Pvt Ltd with revenue of ₹58.68 Cr.
Rini Life Science Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0015958). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rinilifescience.com.
Company details
CIN U51101MP2004PTC016376
Registration Number 016376
Incorporation Date 03 February 2004
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0015958
Key People
Rajnish Chordia Whole-Time Director Rakesh Kumar Chordia Whole-Time Director Gopal Director Recognitions & Rankings of Rini Life Science
Contact details
Rini Life Science Private Limited's registered office is in Indore, Madhya Pradesh. Its website is rinilifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address120 M.T. Cloth Market, Indore, Madhya Pradesh, India
- IndustryPharma, API Manufacturers
To see the full contact details of Rini Life Science Private Limited, buy the company report.
Comprehensive company report
Rini Life Science Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rini Life Science operates one associated brand: Rini Life Science. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes as a CDMO focused on manufacturing active pharmaceutical ingredients. | rinilifescience.com |
Business activity
The main business activity of Rini Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rini Life Science Private Limited, buy the company report.
Financials of Rini Life Science Private Limited
FY 2025 filings availableRini Life Science Private Limited reported revenue of ₹57.3 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹57.3 Cr ▲ 8%
Net profit · FY 2025
₹1.52 Cr margin 2.6%
EBITDA · FY 2025
₹3.67 Cr margin 6.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 13%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 7%
5 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 8% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rini Life Science Private Limited, buy the company report.
Board of directors of Rini Life Science Private Limited
Rini Life Science has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajnish Chordia Also directs: Kriti Exim LLP, Ripride Remedies Private Limited, Shrimant Maharaja Tukojirao Cloth Market Merchants Association and 1 more | Whole-Time Director | 03 Feb 2004 | 22 Years 8 Months | Current |
| Rakesh Kumar Chordia Also directs: Kriti Exim LLP | Whole-Time Director | 03 Feb 2004 | 22 Years 8 Months | Current |
| Gopal | Director | 30 Nov 2019 | 6 Years 10 Months | Current |
Peer comparison
Rini Life Science Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Keshava Organics Pvt Ltd | ₹58.68 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India | |||
| Praveen Laboratories Private Limited | ₹58.06 Cr (FY 2024) | -9.0% | Surat, Gujarat, India | |||
| Lakshmidurga Drugs & Intermediates Private Limited | ₹57.5 Cr (FY 2024) | -17.0% | Hyderabad, Telangana, India | |||
| Rini Life Science Private Limitedthis company | ₹57.3 Cr (FY 2025) | ₹1.52 Cr | 2.6% | 8.0% | 59 | Indore, Madhya Pradesh, India |
| Gensynth Laboratories Private Limited | ₹56.86 Cr (FY 2025) | -29.0% | Patancheru, Telangana, India | |||
| GG Chemicals and Pharmaceuticals Private Limited | ₹56.58 Cr (FY 2025) | -54.0% | Derabassi, Punjab, India | |||
| Siddharth Interchem Private Limited | ₹56.22 Cr (FY 2025) | 60.0% | Ankleshwar, Gujarat, India | |||
| Enal Drugs Pvt Ltd. | ₹55.27 Cr (FY 2024) | -21.0% | Hyderabad, Telangana, India | |||
| Apichem Laboratories Private Limited | ₹55.25 Cr (FY 2024) | 120.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Rini Life Science Private Limited, buy the company report.
Auditor
Rini Life Science Private Limited is audited by Prakash S. Jain & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Prakash S. Jain & Co. | FY 2023 | 002423C |
Shareholding
The shareholding of Rini Life Science Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rini Life Science Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.5 Cr
Satisfied charges
₹86.76 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jul 2014 | 10521337 | Hdfc Bank Limited | ₹2.5 Cr | Open | |
| 18 May 2017 | 100104091 | Hdfc Bank Limited | ₹11.76 Lakh | Satisfied | |
| 17 Feb 2007 | 10036454 | Indore Cloth Market Co Operative Bank Limited | ₹75 Lakh | Satisfied |
To see the full charge records of Rini Life Science Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Rini Life Science Private Limited has 4 deals on record (4 secondary share transfers); the latest was in March 2023.
Total deals
4
Secondary share transfers
4
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Soubhagyamal Ratanchand Chordia Huf, an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Rajnish Kumar Sobhagyamal Chordia Huf, 2 individuals Seller: Sobhagya Mercantile Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: Sobhagya Mercantile Private Limited Seller: Supreem Conductors Limited, Etiem Emedia Limited |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Etiem Emedia Limited, an individual Seller: Stock Word Finlease Private Limited, Express Polyplast Private Limited , Sinner Energy India Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Rini Life Science Private Limited has 6 court cases on record: 4 filed by Rini Life Science, 2 filed against it. 4 cases are pending and 2 are disposed.
Total cases
6
Filed by the company
4
Filed against the company
2
Pending
4
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 2 | 4 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (SC NIA) | Filed by the company against Cian Healthcare Limited and 4 others | Pending |
| District court, Indore, Madhya Pradesh | Court case (UN CR) | Filed by the company against Siyan Helpcare Ltd. and 4 others | Pending |
| District court, Indore, Madhya Pradesh | Court case (MACC) | Filed against the company by an individual | Disposed |
| District court, Indore, Madhya Pradesh | Court case (MACC) | Filed against the company by an individual | Disposed |
To see the full case history of Rini Life Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rini Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rini Life Science Private Limited has a workforce of 59 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
59
Active EPFO establishments
1
GST
Rini Life Science has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCR6758H1Z8 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rini Life Science Private Limited, buy the company report.
Recent activity
Rini Life Science Private Limited has 9 board changes on record since 2004: 6 appointments and 3 cessations. The latest: Gopal was appointed as Director on 30 Nov 2019.
AGM
Rini Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rini Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge registered on 18 May 2017 via Charge ID 100104091 with Hdfc Bank Limited was fully satisfied on 13 Oct 2022.
Charges
A charge with Hdfc Bank Limited of Rs. 2.50 Cr registered on 25 Jul 2014 with Charge ID 10521337 was modified on 02 Mar 2022.
Appointed
Gopal was appointed as Director.
Ceased
Sunil Kumar Bansal ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.12 Cr with Charge ID 100104091 was registered on 18 May 2017.
Charges
A charge registered on 17 Feb 2007 via Charge ID 10036454 with Indore Cloth Market Co Operative Bank Limited was fully satisfied on 21 Mar 2015.
Ceased
Sanjeev Bhatjiwale ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.50 Cr with Charge ID 10521337 was registered on 25 Jul 2014.
Appointed
Sanjeev Bhatjiwale was appointed as Director.
Appointed
Sunil Kumar Bansal was appointed as Director.
7 earlier events are in the company report.
Frequently asked questions
Rini Life Science is an active private limited company based in Indore, Madhya Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 03 February 2004 (22+ years old) and is registered under CIN U51101MP2004PTC016376.
Rini Life Science has 3 current directors:
- Rajnish Chordia - Whole-Time Director
- Rakesh Kumar Chordia - Whole-Time Director
- Gopal - Director
The latest financial statements of Rini Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rini Life Science is 23AACCR6758H1Z8, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Rini Life Science is U51101MP2004PTC016376. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rini Life Science has 6 court cases on record: 4 filed by the company and 2 filed against it. 4 are pending.
Rini Life Science was incorporated on 03 February 2004, making it 22+ years old. It is registered with the Registrar of Companies, Gwalior.
Rini Life Science has 4 deals on record (4 secondary share transfers); the latest was in March 2023.
The peers of Rini Life Science by revenue are Keshava Organics Pvt Ltd, Praveen Laboratories Private Limited, Lakshmidurga Drugs & Intermediates Private Limited, Gensynth Laboratories Private Limited, GG Chemicals and Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gopal was appointed as Director on 30 Nov 2019. Sunil Kumar Bansal ceased to be Director on 31 Mar 2019. Sanjeev Bhatjiwale ceased to be Director on 02 Mar 2015. Rini Life Science has 9 board changes on record in total.
Yes, Rini Life Science is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0015958).